FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

377556002: Phenylephrine hydrochloride + sulfacetamide sodium 1.25mg/150mg solution (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2017. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1202875012 Phenylephrine hydrochloride + sulfacetamide sodium 1.25mg/150mg solution (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1478898019 Phenylephrine hydrochloride+sulfacetamide sodium 1.25mg/150mg solution en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Phenylephrine hydrochloride + sulfacetamide sodium 1.25mg/150mg solution Is a Product containing phenylephrine (medicinal product) false Inferred relationship Some
    Phenylephrine hydrochloride + sulfacetamide sodium 1.25mg/150mg solution Is a Product containing sulfacetamide (medicinal product) false Inferred relationship Some
    Phenylephrine hydrochloride + sulfacetamide sodium 1.25mg/150mg solution Is a Phenylephrine-containing product in ocular dose form false Inferred relationship Some
    Phenylephrine hydrochloride + sulfacetamide sodium 1.25mg/150mg solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Sulfacetamide (substance) false Inferred relationship Some
    Phenylephrine hydrochloride + sulfacetamide sodium 1.25mg/150mg solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Phenylephrine (substance) false Inferred relationship Some
    Phenylephrine hydrochloride + sulfacetamide sodium 1.25mg/150mg solution Is a Phenylephrine hydrochloride + sulfacetamide sodium false Inferred relationship Some
    Phenylephrine hydrochloride + sulfacetamide sodium 1.25mg/150mg solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Phenylephrine hydrochloride (substance) false Inferred relationship Some
    Phenylephrine hydrochloride + sulfacetamide sodium 1.25mg/150mg solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Sulfacetamide sodium false Inferred relationship Some
    Phenylephrine hydrochloride + sulfacetamide sodium 1.25mg/150mg solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Bactericide false Inferred relationship Some
    Phenylephrine hydrochloride + sulfacetamide sodium 1.25mg/150mg solution Has manufactured dose form Ocular dose form (dose form) false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start